Blog
Identifying a Microbial Needle in a Sample Haystack
BlogWe spoke to Dr Jack Regan, CEO of LexaGene, a biotechnology company developing a fully automated pathogen detection platform, and inventor of their patented microfluidic system, about the foundations and evolution of the system, and the future outlook for the tool.
Read More
Deciphering RNA to Predict if a Patient Will Respond to a Targeted Drug
BlogWe recently spoke to Alif Saleh, CEO of Scipher Medicine to learn how RNA data from a patient’s blood sample can be used to determine the underlying molecular processes driving a disease, and establish how well a patient will respond to a particular therapy.
Read More
Microfluidics Solutions to Proteomics Problems
BlogMicrofluidic platforms are becoming commonplace across biological science. To find out more about how microfluidic technology is revolutionizing protein analysis, we spoke to Tuomas Knowles, Founder and Chief Scientific Officer, Fluidic Analytics.
Brain Injury Diagnosed With Single Drop of Blood: a Follow-up
BlogWhat do biomarkers and a 1990s TGIF party have in common? Find out here...
TBIcheck is a rapid point-of-care diagnostic device that detects biomarkers indicative of mild traumatic brain injury. To find out more, we spoke with the head of the Biomedical Proteomics Group, Jean-Charles Sanchez.
Genomics Assures Customers About the Source of Their Meat
BlogHow can meat processors and retailers assure their customers that the meat they are buying is what is declared on the packaging? A genetic fingerprinting system is now on hand to provide definitive, traceable evidence.
Read More
Building a Smart City
BlogCities often don't work very well. Bins don't get collected. Traffic queues are long. Shops run out of goods. The Russian team behind Airalab think that AI can help streamline cities and the economy more widely. Their Robonomics platform aims to make it easier to bring automated, intelligent technology into the economy. With Smart City projects already on the go, from Dubai to Milton Keynes, we spoke to Airalab's Aleksandr Kapitonov to find out more.
Tandem Mass Spectrometry: Rising to Challenges in Clinical Labs
BlogAssay sensitivity and specificity continues to be a challenge in measuring hormones at low concentrations. Tandem mass spectrometry offers significant advantages - particularly in a clinical setting, where speed and sensitivity are required. Following SCIEX' launch of a new tandem mass spectrometry system, we spoke with Michael Jarvis, Product Manager at SCIEX, to find out more.
Read More
Combating Neurodegenerative & Age-related Diseases
BlogWe recently spoke to Karoly Nikolich, chairman and chief executive officer of Alkahest, a clinical-stage biotechnology company, to learn more about their approach to developing therapeutics for both neurodegenerative and age-related diseases.
Read More
Assembling the Pieces of the Genomic Puzzle
BlogOmniTier Inc.’s new bioinformatics platform, CompStorTM Novos, takes a de novo assembly-based variant calling approach to the challenge of whole genome sequencing. We caught up with Jon Coker, Omnitier’s CTO, to discuss how this approach matches up to rival techniques, and how high-performance computing approaches like Omnitier’s hope to bring personalized medicine a step closer and boost biology in coming years.
Read More
What’s New in the Food Analysis Toolkit?
BlogIn areas, such as food analysis where detection of contaminants may be imperative to prevent dangers to consumers, speed and reliability is key. We spoke to Tim Jenkins from Waters Corporation, about their coupling of DART to the QDa mass detector with a software solution aimed to enhance compound identification.
Read More
